Scilex Holding Company (SCLX) Financials

SCLX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 293.6 million 547.7 million
Dec. 31, 2025 365.0 million 576.7 million
Sept. 30, 2025 275.9 million 455.6 million
June 30, 2025 83.8 million 332.7 million

SCLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.2 million 3.6 million
Dec. 31, 2025 -18.0 million 5.6 million
Sept. 30, 2025 8.5 million 3.3 million
June 30, 2025 7.1 million 3.3 million

SCLX Net Income

No data available :(

SCLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 3.4 million 5.6 million 12.7 million
Dec. 31, 2025 11.0 million 27.1 million 13.2 million
Sept. 30, 2025 878000 11.4 million 1.7 million
June 30, 2025 4.1 million - 1.9 million

SCLX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 6.9 million
Dec. 31, 2025 7.0 million
Sept. 30, 2025 11.6 million
June 30, 2025 11.6 million

SCLX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.1 million 3.2 million 31.0 million -
Dec. 31, 2025 134070 8.2 million 29.9 million -
Sept. 30, 2025 300000 3.9 million 188.8 million -
June 30, 2025 4 6.2 million 19.8 million -

SCLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 8.6 million 4.4 million
Dec. 31, 2025 4.8 million 4.2 million
Sept. 30, 2025 10.6 million 3.3 million
June 30, 2025 9.9 million 3.3 million

SCLX

Price: $7.95

52 week price:
2.62
21.34

Earnings Per Share: -40.50 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 81.2 million

Links: